Cargando…
Blockade of IL-10 Signaling Ensures Mifamurtide Efficacy in Metastatic Osteosarcoma
SIMPLE SUMMARY: Osteosarcoma is a highly aggressive and metastasizing primary bone neoplasm with poor patient survival rates. Mifamurtide is an immunostimulant drug whose clinical efficacy is still debated. Here we identified IL-10 as a new possible target useful to improve mifamurtide effectiveness...
Autores principales: | Nastasi, Nicoletta, Pasha, Amada, Bruno, Gennaro, Subbiani, Angela, Pietrovito, Laura, Leo, Angela, Scala, Lucia, de Simone, Lorena, Casazza, Gabriella, Lunardi, Federica, Taddei, Maria Letizia, Tamburini, Angela, Tondo, Annalisa, Favre, Claudio, Calvani, Maura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571595/ https://www.ncbi.nlm.nih.gov/pubmed/37835437 http://dx.doi.org/10.3390/cancers15194744 |
Ejemplares similares
-
Beta-Blockers and Berberine: A Possible Dual Approach to Contrast Neuroblastoma Growth and Progression
por: Calvani, Maura, et al.
Publicado: (2020) -
β3-Adrenoreceptor Blockade Induces Stem Cells Differentiation in Melanoma Microenvironment
por: Calvani, Maura, et al.
Publicado: (2020) -
Spotlight on ROS and β3-Adrenoreceptors Fighting in Cancer Cells
por: Calvani, Maura, et al.
Publicado: (2019) -
β2-and β3-Adrenergic Receptors Contribute to Cancer-Evoked Pain in a Mouse Model of Osteosarcoma via Modulation of Neural Macrophages
por: Bruno, Gennaro, et al.
Publicado: (2021) -
β3-adrenergic receptor on tumor-infiltrating lymphocytes sustains IFN-γ-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma
por: Bruno, Gennaro, et al.
Publicado: (2023)